ENTX insider transaction filings
Entera Bio Ltd. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen ENTX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 9 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Toledano Miranda Jayne — Chief Executive Officer, Director | 2 | — | — | 4 |
| Germano Geno J — Director | 1 | — | — | 3 |
| Ellis Sean — Director | 1 | — | — | 2 |
| Burshtein Gregory — Chief of R&D | 1 | — | — | 1 |
| Galitzer Hillel — Chief Operating Officer | 1 | — | — | 1 |
| Malca Yonatan — Director | 1 | — | — | 1 |
| Taitel Haya — Director | 1 | — | — | 1 |
| Yaacov-Garbeli Dana — Chief Financial Officer | 1 | — | — | 1 |
Recent Form 4 filings — Entera Bio Ltd.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Ellis Sean — Director | Grant/award (A): 20,034 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Taitel Haya — Director | Grant/award (A): 20,790 @ $0 | EDGAR |
| 2026-08-07 | 4 | Malca Yonatan — Director | Grant/award (A): 22,815 @ $0 | EDGAR |
| 2026-08-07 | 4 | Germano Geno J — Director | Grant/award (A): 25,014 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 43,014 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Toledano Miranda Jayne — Chief Executive Officer, Director | Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Burshtein Gregory — Chief of R&D | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Galitzer Hillel — Chief Operating Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Yaacov-Garbeli Dana — Chief Financial Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | Toledano Miranda Jayne — Chief Executive Officer, Director | Grant/award (A): 347,567 @ $0 · Grant/award (A): 72,993 @ $0 | EDGAR |
| 2026-05-08 | 4 | Galitzer Hillel — Chief Operating Officer | Grant/award (A): 72,993 @ $0 | EDGAR |
| 2026-05-08 | 4 | Yaacov-Garbeli Dana — Chief Financial Officer | Grant/award (A): 58,394 @ $0 | EDGAR |
| 2026-05-08 | 4 | Burshtein Gregory — Chief of R&D | Grant/award (A): 87,591 @ $0 | EDGAR |
| 2026-03-11 | 4 | Germano Geno J — Director | Purchase (P): 20,000 @ $1.30 | EDGAR |
| 2026-03-09 | 4 | Ellis Sean — Director | Purchase (P): 10,000 @ $1.23 | EDGAR |
| 2026-02-11 | 4 | Taitel Haya — Director | Purchase (P): 7,500 @ $1.48 | EDGAR |
| 2026-02-11 | 4 | Ellis Sean — Director | Purchase (P): 18,000 @ $1.24 | EDGAR |
| 2026-02-11 | 4 | Germano Geno J — Director | Purchase (P): 20,000 @ $1.49 | EDGAR |
| 2026-01-02 | 4 | Ellis Sean — Director | Grant/award (A): 25,371 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Malca Yonatan — Director | Grant/award (A): 30,157 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Taitel Haya — Director | Grant/award (A): 26,329 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | OSTROV GERALD M — Director | Grant/award (A): 28,721 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 38,294 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Toledano Miranda Jayne — Chief Executive Officer, Director | Purchase (P): 11,000 @ $1.81 | EDGAR |
| 2025-07-18 | 4 | Toledano Miranda Jayne — Chief Executive Officer, Director | Grant/award (A): 136,842 @ $0 · Grant/award (A): 43,860 @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Burshtein Gregory — Chief of R&D | Grant/award (A): 26,316 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Yaacov-Garbeli Dana — Chief Financial Officer | Grant/award (A): 26,316 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Galitzer Hillel — Chief Operating Officer | Grant/award (A): 26,316 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | LIEBERMAN GERALD M — Director | Option exercise (M): 23,952 @ $1 · Option exercise (M): 23,952 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Malca Yonatan — Director | Grant/award (A): 8,216 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Taitel Haya — Director | Grant/award (A): 6,922 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Ellis Sean — Director | Grant/award (A): 7,100 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | OSTROV GERALD M — Director | Grant/award (A): 8,038 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 10,717 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Taitel Haya — Director | Grant/award (A): 7,278 @ $0 | EDGAR |
| 2024-10-04 | 4 | Malca Yonatan — Director | Grant/award (A): 8,639 @ $0 | EDGAR |
| 2024-10-04 | 4 | Ellis Sean — Director | Grant/award (A): 7,466 @ $0 | EDGAR |
| 2024-10-04 | 4 | OSTROV GERALD M — Director | Grant/award (A): 8,452 @ $0 | EDGAR |
| 2024-10-04 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 11,269 @ $0 | EDGAR |
| 2024-08-29 | 4 | Taitel Haya — Director | Grant/award (A): 15,335 @ $0 | EDGAR |
| 2024-08-29 | 4 | Ellis Sean — Director | Grant/award (A): 18,061 @ $0 | EDGAR |
| 2024-08-29 | 4 | Malca Yonatan — Director | Grant/award (A): 23,172 @ $0 | EDGAR |
| 2024-08-29 | 4 | OSTROV GERALD M — Director | Grant/award (A): 20,446 @ $0 | EDGAR |
| 2024-08-29 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 27,261 @ $0 | EDGAR |
| 2024-08-02 | 4 | Toledano Miranda Jayne — Chief Executive Officer, Director | Grant/award (A): 124,121 @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-08-02 | 4/A | Yaacov-Garbeli Dana — Chief Financial Officer | Grant/award (A): 30,151 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-04-23 | 4 | Yaacov-Garbeli Dana — Chief Financial Officer | Grant/award (A): 30,151 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-04-23 | 4 | Galitzer Hillel — Chief Operating Officer | Grant/award (A): 30,151 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Taitel Haya — Director | Purchase (P): 9,500 @ $0.99 | EDGAR |
| 2024-01-11 | 4 | Taitel Haya — Director | Purchase (P): 7,615 @ $0.77 | EDGAR |
| 2024-01-03 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 108,333 (derivative) @ $0 | EDGAR |
Recent 8-K events — Entera Bio Ltd.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →